| 영문 | gene therapy | 한글 | 유전자요법 |
|---|---|---|---|
| 설명 | 유전병을 치료할 목적으로, 정상적으로 기능하는 단일유전자 혹은 복수유전자를 어떤 기원에서 얻어내어 생세포에 도입하는 것. 유전물질은 유전자삽입 조작에 의해 수용세포에로 도입된다. 즉, 유전자를 끼워 넣은 새로운 세포를 사용하는 치료로서 1980년 미국의 학자가 지중해빈혈환자에게 강행하여 비판을 받았지만, 미국 국립보건연구소는 1990년 9월 아데노신 데아미나아제(adenosine deaminase, ADA) 결핍증 환자의 림프구에 ADA 유전자를 끼워 넣는 치료를 시작한 이래 현재는 암을 포함한 많은 질병들을 치료하는 목적으로 쓰인다. |
||
| 영문 | Electric convulsive therapy(ECT) | 한글 | 전기경련요법 |
|---|---|---|---|
| 설명 | 뇌에 전기 자극을 주어 인위적으로 경련을 유발함으로써 정신 병을 치료하는 방법. 전기쇼크요법(electroshock therapy)이라고도 한다. 1938년에 이탈리아의 체를레티와 비니에 의해 시작되었다. 작용기전은 확실치 않으나 뇌의 신진대사, 생화학 및 효소 등에 변화를 일으킨다는 생물학적, 생화학적 학설이 유력하다. 적응증으로 가장 효과적인 병은 우울증으로 특히 여성에서 갱년기에 호발하는 갱년기 우울증, 우울증과 조증(아주 기분이 좋은 상태가 지속되는 정신병)이 일정한 주기를 두고 반복하는 조울증에 잘 쓰이며, 80~90%에서 효과가 있다. |
||
| PT | pain threshold; parathormone; parathyroid; paroxysmal tachycardia; part time; patient; pericardial t... |
|---|---|
| CHT | chemotherapy; combined hormone therapy; contralateral head turning |
| APR | abdominoperineal resection; absolute proximal reabsorption; acute phase reaction or reactant; amebic... |
| ARR | aortic root replacement |
| AVR | accelerated ventricular rhythm; antiviral regulator; aortic valve replacement |
| LRH | Luteinizing Hormone Releasing Hormone |
|---|---|
| LHRH-A | luteinizing hormone releasing hormone agonist |
| LHRHa | leuteinizing hormone-releasing hormone analogue |
| PTH/PTHrP | Parathyroid hormone/parathyroid-hormone-related peptide |
| GnRH | gonadotropin hormone releasing hormone |
| biological therapy | <oncology> Treatment with substances that can stimulate the immune system to fight disease more effectively. Synonym: immunotherapy. (16 Dec 1997) |
|---|---|
| boron neutron capture therapy | A technique for the treatment of neoplasms, especially gliomas and melanomas in which boron-10, an isotope, is introduced into the target cells followed by irradiation with thermal neutrons. (12 Dec 1998) |
| bovine growth hormone | <endocrinology> A hormone secreted by the bovine pituitary gland. It is used to increase milk production by improving the feed efficiency in dairy cattle. (14 Nov 1997) |
| cardiac hormone | A substance present in extracts of cardiac tissue that augments cardiac contraction; possibly adenosine, a catecholamine, or some non-specific stimulant present generally in tissues. Synonym: cardiac hormone, heart hormone. (05 Mar 2000) |
| galactopoietic hormone | <protein> Pituitary lactogenic hormone (23 kD) Synthesised on endoplasmic reticulum bound ribosomes as preprolactin that has an N terminal signal peptide that is cleaved from the mature form. The conversion of preprolactin to prolactin has been much used as an assay for membrane insertion. (18 Nov 1997) |
| radiation therapy | <radiobiology> Treatment with high energy radiation from X-rays or other sources of radiation. (16 Dec 1997) |
| gametokinetic hormone | An acidic glycoprotein hormone of the anterior pituitary that stimulates the graafian follicles of the ovary and assists subsequently in follicular maturation and the secretion of estradiol; in the male, it stimulates the epithelium of the seminiferous tubules and is partially responsible for inducing spermatogenesis. Synonym: follicle-stimulating hormone, follicle-stimulating principle, gametokinetic hormone. Origin: follicle + G. Trope, a turning, + -in (05 Mar 2000) |
| radium beam therapy | Therapeutic use of radium rays, the source of which is a quantity of radium at a distance from the patient. Synonym: radium beam therapy. (05 Mar 2000) |
| palliative therapy | <procedure> A procedure such as chemotherapy, radiation therapy or surgery that is performed to relieve or ease pain or other symptoms. (16 Dec 1997) |
| maintenance drug therapy | In chemotherapy, systematic dosage at a level that maintains protection against exacerbation. (05 Mar 2000) |
| maintenance therapy | Extended drug therapy, usually at a diminished dose, administered after a disease has been brought under control. Maintenance therapy is utilised when a complete cure is not possible, and a disease is likely to recur if therapy is halted. (09 Oct 1997) |
| pancreatic hyperglycaemic hormone | A polypeptide hormone (3485 D) secreted by the cells of the Islets of Langerhans in response to a fall in blood sugar levels. Induces hyperglycaemia. A family of structurally related peptides includes glucagon like peptides 1 & 2 (encoded by the same gene), gastric inhibitory polypeptide, secretin, vasoactive intestinal peptide, growth hormone releasing factor, pituitary adenylate cyclase activating polypeptide, exendins. (18 Nov 1997) |
| gastrointestinal hormone | <endocrinology> A general term for any hormone which is secreted by some part of the digestive system for the purpose of aiding digestion. For example: gastrin. (09 Oct 1997) |
| mammotropic hormone | <protein> Pituitary lactogenic hormone (23 kD) Synthesised on endoplasmic reticulum bound ribosomes as preprolactin that has an N terminal signal peptide that is cleaved from the mature form. The conversion of preprolactin to prolactin has been much used as an assay for membrane insertion. (18 Nov 1997) |
| rational therapy | Therapeutic procedures introduced by Albert Ellis and based on the premise that lack of information or illogical thought patterns are basic causes of a patient's difficulties; it is assumed that the patient can be assisted in overcoming his or her problems by a direct, prescriptive, advice-giving approach by the therapist. (05 Mar 2000) |
| hormone replacement therapy |
The use of hormones such as oestrogen or a combination of oestrogen and progestogen/progesterone for the relief of symptoms resulting from cessation of ovarian function, either at the time of the natural menopause or following surgical removal of the ovaries.
출처: www.soyfacts.com.au/glossary.html
|
|---|---|
| hormone replacement therapy |
Hormones, eg testosterone in males, estrogen in females, may be prescribed when a deficiency is found.
출처: www.malehealth.com/HTML/B9_print.html
|
| hormone replacement therapy |
A program of subsidising the body's supply of hormones with additional hormones in order to restore vitality. The most common HRT involves oestrogen replacement for menopausal women. There is some concern that taking oestrogen after natural production stops might be harmful.
출처: www.sportcentric.com/vsite/vcontent/page/custom/0,...
|
| hormone replacement therapy |
Use of HRT for more than 5 years has been shown to slightly increase the risk of breast cancer and risk increases with longer use.
출처: www.nortonhealthcare.com/healthinfo/adam/1/000913....
|